Biologik ApS: Financial statements 2022
CVR: 36070498
Biologik ApS (CVR 36070498) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 258,073 and a net result of DKK -89,361 compared with DKK 214,892 the year before. That is a decrease of 56.5% compared with the year before. Equity amounted to DKK 267,866. The solvency ratio was 61.2%. The company had 1 employee in the financial year.
- Gross Profit
- 258,073 kr.
- Profit/Loss
- -89,361 kr.
- Equity
- 267,866 kr.
- Total Assets
- 437,363 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 258 t. | -89 t. | 268 t. | 1 |
| 2021 | - | 593 t. | 215 t. | 414 t. | 1 |
| 2020 | - | 378 t. | 62 t. | 199 t. | 1 |
| 2019 | - | 832 t. | 183 t. | 237 t. | 1 |
| 2018 | - | 714 t. | 174 t. | 107 t. | 1 |
Keep an eye on Biologik ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Biologik ApS
Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity amounted to DKK 408,578.
